Get started
Author

Kristýna Kubíčková

Observed names: K Kubickova, K Kubíčková, Kristy Na Kubícková, Kristyna Kubickova, Kubíčková, Kristyna
Institution: Iscare I.V.F
ORCID: 0000-0003-1257-9171
Observed ORCID: 0000-0003-1257-9171
OpenAlex ID: A5058772393
Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study
2021 · Karin Cerna, Dana Duricova, et al. · Inflammatory Bowel Diseases · 30
Subcutaneous Infliximab in Refractory Crohn’s Disease Patients: A Possible Biobetter?
2023 · Karin Cerna, Dana Duricova, et al. · Crohn s & Colitis 360 · 19
PDF
Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients
2022 · Karin Cerna, Dana Duricova, et al. · Journal of Crohn s and Colitis · 15
PDF
Predictive role BLVRA mRNA expression in hepatocellular cancer.
2016 · Kristy Na Kubícková, Iva Subhanová, et al. · PubMed · 15
Expression of Biliverdin Reductase A in Peripheral Blood Leukocytes Is Associated with Treatment Response in HCV-Infected Patients
2013 · Iva Subhanova, Lucie Muchova, et al. · PLoS ONE · 13
PDF
Efficacy of blood plasma spectroscopy for early liver cancer diagnostics in obese patients
2024 · Petr Hříbek, Ondřej Vrtělka, et al. · Annals of Hepatology · 8
P0591 Janus Kinase Inhibitors Improve Liver Biochemistry in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: an ECCO CONFER Study.
2025 · A Soriano, D Maggi, et al. · Journal of Crohn s and Colitis · 3
PDF
P408 Dual therapy with vedolizumab and tofacitinib in refractory ulcerative colitis patients – single centre experience
2023 · M Kolar, K Kastylova, et al. · Journal of Crohn s and Colitis · 2
PDF
Vedolizumab Plus Curcumin-qingdai for Patients With Ulcerative Colitis
2025 · štěpán Peterka, Martin Lukáš, et al. · Gastroenterology · 1
Vedolizumab Plus Curcumin-qingdai for Patients With Ulcerative Colitis
2025 · štěpán Peterka, Martin Lukáš, et al. · Inflammatory Bowel Diseases · 1
PDF
Subcutaneous infliximab in the treatment of refractory Crohn‘s disease patients – a pilot study of drug immunogenicity
2023 · Karin Černá, Dana Ďuricová, et al. · Gastroenterologie a hepatologie · 1
Efficiency of Dual Therapy With Vedolizumab and Tofacitinib in Refractory Ulcerative Colitis Patients – Single Centre Experience
2023 · Martin Kolar, Kristyna Kastylova, et al. · Gastroenterology · 1
PDF
Efficiency of Dual Therapy With Vedolizumab and Tofacitinib in Refractory Ulcerative Colitis Patients – Single Centre Experience
2023 · Martin Kolar, Kristyna Kastylova, et al. · Inflammatory Bowel Diseases · 1
PDF
Dual Biological or Small Molecule Treatment in Inflammatory Bowel Diseases: Data From Clinical Practice
2022 · Milan Lukas, Martin Kolar, et al. · Gastroenterology · 1
The potential of spectroscopy in the diagnosis of hepatocellular carcinoma – a pilot study
2021 · Petr Hříbek, Lucie Habartová, et al. · Gastroenterologie a hepatologie · 1
Hepatitis E Infection in Patients With IBD Treated With Advanced Therapy: A Case Series
2026 · Jakub Jirsa, Kristyna Kubickova, et al. · JCC Plus
P0476 Hepatitis E infection in patients with IBD treated with advanced therapy: a case series
2026 · J Jirsa, K Kubickova, et al. · Journal of Crohn s and Colitis
Laboratory Diagnosis of Hepatocellular Carcinoma - Conventional Biomarkers and Blood Plasma Spectroscopy
2023 · Petr Hříbek, Lucie Habartová, et al. · Military Medical Science Letters
PDF
Dual Biological or Small Molecule Treatment in Inflammatory Bowel Diseases: Data From Clinical Practice
2022 · Milan Lukas, Martin Kolar, et al. · Inflammatory Bowel Diseases
PDF
[ART score prognostic significance in patients with intermediate hepatocellular carcinoma].
2016 · Petr Hříbek, Kristýna Kubíčková, et al. · PubMed
Works count: 21
Citation count: 112
H-index: 6
I10-index: 5
Year
Topic
Type